Martek Biosciences Corp. 2Q profit rises 20 percent - Baltimore Business Journal:

retention-jackjacks.blogspot.com
The company reported $92.4 million in revenue for the quartere endingApril 30, up 2 percent from the same period last year. It earned $11 million in net or 33 cents perdiluted share, during the second compared with $9.2 million, or 28 cents per dilutef share, during the second quartet of last year. Analysts polledr by expected the company to earn 29 centsw per shareand $89 million in Martek (NASDAQ: MATK) sells nutritional oils derived from algae that are used in infanf formula, dietary supplements and food products such as yogurtf and juice. Sales of its nutritional supplements to the nursing market rose to arecordc $9.8 million.
But the companyg warned that its infant formula sales in the thirsd and fourth quarters could drop as retailerd trim their inventories ofthe product. The company anticipates that infanrt formula revenue will grow in fiscalp 2010 as a resulgt of strong demand for infant formula products containing its nutritional oils DHAand ARA. The Omega-2 fatty acids are believed to play an importanty role in brain andeye development. studyh that could show that Martek’sz DHA can slow the progressionof Alzheimer’zs disease.